John Lepore, ProFound Therapeutics CEO
October 2, 2023 02:51 PM EDTUpdated 04:32 PM
People
Startups

Flag­ship poach­es an­oth­er phar­ma R&D leader as GSK's Lep­ore heads to Pro­Found

Kyle LaHucik

Senior Reporter

John Lep­ore, the for­mer right-hand man for Hal Bar­ron and Tony Wood at GSK, is de­part­ing the UK phar­ma gi­ant to lead a Flag­ship …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

A service from the Financial Times